Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pentoxifylline. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Cetirizine In The Dosage Forms Tro And Tei. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pamidronic Acid. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Benazepril + Hct (fta) 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Combination Calcium Ion + Colecalciferol In The Dosage Forms Kta And Bta In The Pack Size Of 100 Pcs. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Combination Paracetamol + Codeine In The Dosage Forms Tab And Hkp. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bezafibrate In The Dosage Form Fta. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130a Paragraph 8 Sgb V With The Active Ingredient Mycophenolic Acid In The Dosage Form Pse. 2026-11-10
Bulgaria Delivery Of Medical Devices For Umbal "st. Ivan Rilski" Ead 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ibuprofen 200 Mg In The Dosage Form Fta 2026-11-10
Whats app